Blog
RSS FeedPosted by Michael Wonder on 20 May 2025
Redefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC – a systematic literature review
14 May 2025 - This study explored patient involvement in health care decision-making in the Asia-Pacific region by identifying roles and ...
Posted by Michael Wonder on 09 May 2025
DoH publishes revised agenda for the July 2025 PBAC meeting
9 May 2025 - The agenda for the July 2025 PBAC meeting has been updated. ...
Posted by Michael Wonder on 02 May 2025
DoH publishes revised agenda for the May 2025 PBAC meeting
2 May 2025 - The agenda for the May 2025 PBAC meeting has been updated. ...
Posted by Michael Wonder on 27 Apr 2025
Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 PBAC meeting
24 April 2025 - The Public Summary Documents (first-time decisions not to recommend and deferrals) from the December 2024 PBAC meeting ...
Posted by Michael Wonder on 27 Apr 2025
Recommendations made by the PBAC – March 2025
24 April 2025 - Recommendations made by the PBAC in March 2025 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 25 Apr 2025
Multiple myeloma drug subsidised after treatment costs ballooned
24 April 2025 - It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely ...
Posted by Michael Wonder on 12 Apr 2025
Public Summary Documents – December 2024 PBAC meeting
11 April 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2024 PBAC ...
Posted by Michael Wonder on 02 Apr 2025
Agenda for the July 2025 PBAC meeting
2 April 2025 - The agenda for the July 2025 PBAC meeting is now available. ...
Posted by Michael Wonder on 21 Mar 2025
Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 07 Mar 2025
Public Summary Documents – November 2024 PBAC meeting
7 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 17 Feb 2025
Unravelling the association between uncertainties in model-based economic analysis and funding recommendations of medicines in Australia
14 February 2025 - Health technology assessment is used extensively by the PBAC to inform medicine funding recommendations in Australia. ...
Posted by Michael Wonder on 02 Feb 2025
Public consultation: draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
31 January 2025 - Consultation on the draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and ...
Posted by Michael Wonder on 31 Jan 2025
Outcomes from the December 2024 PBAC meeting
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 27 Dec 2024
Bureaucratic ‘deficiencies’ in medicine funding underscore access crisis
26 December 2024 - The Government’s independent medicine funding assessor, still recovering from a public failure to process months worth ...
Posted by Michael Wonder on 24 Dec 2024
Public Summary Documents – September 2024 PBAC meeting
24 December 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2024 PBAC ...